nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—OPRD1—forebrain—attention deficit hyperactivity disorder	0.0337	0.11	CbGeAlD
Dextropropoxyphene—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0323	0.106	CbGeAlD
Dextropropoxyphene—OPRM1—forebrain—attention deficit hyperactivity disorder	0.023	0.0751	CbGeAlD
Dextropropoxyphene—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.0217	0.189	CrCbGaD
Dextropropoxyphene—Bepridil—CACNA1C—attention deficit hyperactivity disorder	0.0205	0.178	CrCbGaD
Dextropropoxyphene—OPRD1—nervous system—attention deficit hyperactivity disorder	0.0183	0.0598	CbGeAlD
Dextropropoxyphene—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.0176	0.0576	CbGeAlD
Dextropropoxyphene—OPRK1—nervous system—attention deficit hyperactivity disorder	0.0175	0.0573	CbGeAlD
Dextropropoxyphene—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.0169	0.0552	CbGeAlD
Dextropropoxyphene—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.0165	0.0539	CbGeAlD
Dextropropoxyphene—OPRM1—midbrain—attention deficit hyperactivity disorder	0.0152	0.0496	CbGeAlD
Dextropropoxyphene—OPRD1—brain—attention deficit hyperactivity disorder	0.014	0.0457	CbGeAlD
Dextropropoxyphene—OPRK1—brain—attention deficit hyperactivity disorder	0.0134	0.0438	CbGeAlD
Dextropropoxyphene—OPRM1—nervous system—attention deficit hyperactivity disorder	0.0125	0.0408	CbGeAlD
Dextropropoxyphene—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.012	0.0393	CbGeAlD
Dextropropoxyphene—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.0114	0.0991	CrCbGaD
Dextropropoxyphene—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0104	0.0339	CbGeAlD
Dextropropoxyphene—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00988	0.0859	CrCbGaD
Dextropropoxyphene—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00968	0.0842	CrCbGaD
Dextropropoxyphene—OPRM1—brain—attention deficit hyperactivity disorder	0.00952	0.0312	CbGeAlD
Dextropropoxyphene—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00925	0.0805	CrCbGaD
Dextropropoxyphene—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0092	0.0301	CbGeAlD
Dextropropoxyphene—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.00806	0.0701	CrCbGaD
Dextropropoxyphene—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.0079	0.0687	CrCbGaD
Dextropropoxyphene—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.00603	0.0524	CrCbGaD
Dextropropoxyphene—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.00599	0.0521	CrCbGaD
Dextropropoxyphene—CYP2C8—brain—attention deficit hyperactivity disorder	0.00573	0.0187	CbGeAlD
Dextropropoxyphene—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00508	0.0166	CbGeAlD
Dextropropoxyphene—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.005	0.0163	CbGeAlD
Dextropropoxyphene—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00489	0.016	CbGeAlD
Dextropropoxyphene—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00481	0.0157	CbGeAlD
Dextropropoxyphene—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.0047	0.0154	CbGeAlD
Dextropropoxyphene—Trimipramine—HTR2A—attention deficit hyperactivity disorder	0.00463	0.0403	CrCbGaD
Dextropropoxyphene—CYP2D6—brain—attention deficit hyperactivity disorder	0.00382	0.0125	CbGeAlD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00325	0.00561	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00324	0.00559	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00321	0.00555	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.0032	0.00552	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00316	0.00545	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00312	0.00538	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00311	0.00537	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00311	0.00537	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0031	0.00536	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00305	0.00527	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00305	0.00526	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00304	0.00525	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00302	0.00521	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00297	0.00512	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00295	0.00509	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00294	0.00508	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00293	0.00506	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0029	0.005	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00287	0.00496	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00286	0.00494	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00285	0.00492	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00283	0.00489	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00282	0.00487	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00278	0.0048	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00278	0.00479	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00275	0.00474	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00273	0.00471	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.0027	0.00466	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00267	0.00461	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00267	0.0046	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00267	0.0046	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00263	0.00455	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00262	0.00453	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00259	0.00446	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00255	0.0044	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00254	0.00439	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00251	0.00433	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00251	0.00433	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0025	0.00432	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00249	0.0043	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00249	0.00429	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00248	0.00427	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00243	0.00419	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00238	0.00411	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00237	0.0041	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00237	0.0041	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00236	0.00407	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00234	0.00404	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00234	0.00404	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00233	0.00401	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00232	0.004	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00231	0.00398	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00228	0.00394	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00226	0.0039	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00226	0.00389	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00225	0.00388	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00221	0.00381	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00219	0.00377	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00219	0.00377	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00218	0.00376	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00218	0.00376	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00216	0.00372	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00215	0.00371	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00212	0.00366	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00211	0.00365	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00211	0.00365	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00208	0.00359	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00204	0.00352	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00203	0.00351	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00203	0.0035	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00198	0.00341	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00197	0.0034	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00194	0.00334	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00191	0.0033	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00191	0.0033	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0019	0.00328	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00189	0.00326	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00187	0.00322	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00185	0.0032	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00185	0.00319	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00178	0.00307	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00176	0.00304	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00172	0.00298	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00172	0.00297	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00167	0.00287	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00166	0.00287	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00164	0.00283	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00164	0.00282	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00162	0.00279	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00162	0.00279	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00161	0.00278	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0016	0.00276	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00157	0.0027	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0015	0.0026	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00149	0.00257	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00149	0.00257	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00148	0.00256	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00148	0.00255	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00147	0.00253	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00146	0.00253	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00142	0.00245	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00141	0.00244	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00141	0.00243	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00141	0.00243	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00138	0.00239	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00131	0.00226	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0013	0.00224	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00128	0.00222	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00128	0.00221	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00127	0.0022	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00127	0.00219	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00125	0.00215	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00125	0.00215	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00125	0.00215	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00124	0.00213	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00123	0.00213	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00122	0.00211	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00122	0.00211	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00121	0.00209	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00121	0.00209	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0012	0.00208	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.0012	0.00207	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00119	0.00206	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00119	0.00206	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00119	0.00205	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00115	0.00199	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00115	0.00198	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00115	0.00198	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00113	0.00195	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00112	0.00194	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00112	0.00193	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00112	0.00193	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00111	0.00192	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0011	0.0019	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00109	0.00189	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00189	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00109	0.00187	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00108	0.00186	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00107	0.00185	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00105	0.00182	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00104	0.0018	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00104	0.0018	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00104	0.0018	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00101	0.00174	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00101	0.00174	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000993	0.00171	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000981	0.00169	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000971	0.00168	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000971	0.00168	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000948	0.00164	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000944	0.00163	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00094	0.00162	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000925	0.0016	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000924	0.0016	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000914	0.00158	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000913	0.00158	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000907	0.00157	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000882	0.00152	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000865	0.00149	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000854	0.00147	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00085	0.00147	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000839	0.00145	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000829	0.00143	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000804	0.00139	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000798	0.00138	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000792	0.00137	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000787	0.00136	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000772	0.00133	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000758	0.00131	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000756	0.0013	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00073	0.00126	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000705	0.00122	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000703	0.00121	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000681	0.00117	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00067	0.00116	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00067	0.00116	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000669	0.00115	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000663	0.00114	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000661	0.00114	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000659	0.00114	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000641	0.00111	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00064	0.0011	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000616	0.00106	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000616	0.00106	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000613	0.00106	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000608	0.00105	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000597	0.00103	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000596	0.00103	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000587	0.00101	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000579	0.001	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00056	0.000967	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000541	0.000934	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00054	0.000932	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000536	0.000925	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000521	0.000899	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00051	0.00088	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000504	0.000871	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000499	0.000861	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000496	0.000856	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000495	0.000854	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00049	0.000845	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000456	0.000787	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000431	0.000744	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00042	0.000724	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00042	0.000724	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000413	0.000712	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000406	0.000701	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000403	0.000696	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000384	0.000662	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000378	0.000652	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000344	0.000595	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000344	0.000595	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000341	0.000589	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000341	0.000589	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000339	0.000585	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000336	0.00058	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000335	0.000579	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000326	0.000563	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00032	0.000551	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000319	0.000551	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000315	0.000544	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000312	0.000539	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000275	0.000475	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000273	0.000471	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000262	0.000452	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00026	0.000449	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000254	0.000439	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000252	0.000436	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000245	0.000422	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000228	0.000394	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000225	0.000389	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000225	0.000389	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000222	0.000382	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000209	0.00036	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000207	0.000358	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000207	0.000357	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000206	0.000355	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000205	0.000355	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.0002	0.000346	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000199	0.000344	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00018	0.000311	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000174	0.000301	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000171	0.000296	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000169	0.000292	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000136	0.000235	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000135	0.000234	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	0.000109	0.000188	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	8.95e-05	0.000154	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	8.87e-05	0.000153	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	5.85e-05	0.000101	CbGpPWpGaD
